查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1437515

嗎啡藥物市場，按劑型、按應用、配銷通路、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Morphine Drugs Market, By Dosage Form, By Application, By Distribution Channel, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 287 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年嗎啡藥物市場規模為 228.7 億美元，2024 年至 2032 年複合CAGR為 4.5%。

嗎啡藥物市場-市場動態

老年人口的增加以及慢性病推動了市場的成長

在預測期內，由於老年人口不斷成長和慢性病盛行率上升，對嗎啡等不同鴉片類藥物的需求預計將會上升。慢性疼痛和骨關節炎疾病在老年族群中更為常見。 2021 年 5 月，MDPI 發布的一份報告表明，慢性疼痛是影響超過 50% 老年人口的重大問題。此外，據預測，關節炎盛行率的上升將增加對止痛藥的需求。加拿大關節炎協會估計，65 歲以上的人中有 50% 患有關節炎。因此，在預測期內，全球遭受慢性疼痛的人數不斷增加，預計將推動嗎啡市場的發展。

嗎啡藥物市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 4.5% 左右的CAGR成長

根據劑型細分，預計注射劑將在 2023 年佔據最大市場佔有率

基於應用細分，疼痛管理是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

嗎啡藥物市場-細分分析：

全球嗎啡藥物市場根據劑型、應用、配銷通路、最終用途和地區進行細分。

根據劑型，市場分為三類：口服、注射和其他。注塑產業在市場上佔據主導地位。這些注射的目的是緩解中度至重度疼痛。它也可以在手術前或手術期間與麻醉劑一起使用。該市場的公司包括 Duramorph、Infumorph 和 Astramorph PF。

根據應用，市場分為兩類：止瀉藥、止痛藥、感冒止咳藥和其他。疼痛管理領域在市場上佔據主導地位，由於嗎啡作為止痛藥的廣泛使用，在預測期內可能會保持其主導地位。它可用於治療或減輕多種疾病引起的疼痛，包括事故造成的嚴重創傷、分娩疼痛、癌症疼痛和手術疼痛。

嗎啡藥物市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。在老牌企業的存在下，市場預計將更強勁地擴張。在預測期內，肌肉骨骼疾病的日益普及和製藥行業的強勁需求預計也將支持該地區的擴張。根據司法部和緝毒局 2020 年 4 月發布的情況說明書，從鴉片提領的嗎啡在美國直接用於醫藥產品。因此，在預測期內，該地區的市場需求可能會受到嗎啡在製藥業的使用的推動。

嗎啡藥物市場-競爭格局：

嗎啡藥物市場的市場參與者包括輝瑞公司、Mallinckrodt Pharmaceuticals、艾伯維公司、Delpharm（山德士加拿大公司）、雷迪博士實驗室有限公司（梅恩製藥Group Limited）、第一三共有限公司、Verve Health Care Ltd 、Hikma Pharmaceuticals USA Inc.、Sun Pharmaceutical Industries Ltd、Viatris Inc.、Alcaliber SA 和賽諾菲等。這些參與者採取了各種策略來維持最大的市場佔有率，例如產品發布、收購、擴張等。

最近的發展：

2022 年 7 月，Bryant Ranch Prepack Inc. 主動從消費者分銷中召回了一批 30 毫克和一批 60 毫克的硫酸嗎啡緩釋片（各 10 瓶）。

目錄

第 1 章：嗎啡藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 嗎啡藥物市場片段（按劑型）
    • 嗎啡藥物市場片段（依應用）
    • 嗎啡藥物市場片段（依配銷通路）
    • 嗎啡藥物市場片段（依最終用途）
    • 嗎啡藥物市場片段（按國家/地區）
    • 嗎啡藥物市場片段（按地區）
  • 競爭洞察

第 3 章：嗎啡藥物主要市場趨勢

  • 嗎啡藥物市場促進因素
    • 市場促進因素的影響分析
  • 嗎啡藥物市場限制
    • 市場限制影響分析
  • 嗎啡藥物市場機會
  • 嗎啡藥物市場未來趨勢

第 4 章：嗎啡藥品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：嗎啡藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：嗎啡藥物市場格局

  • 2023 年嗎啡藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：嗎啡藥物市場 - 按劑型

  • 概述
    • 按劑型分類的細分市場佔有率分析
    • 口服
    • 注射
    • 其他

第 8 章：嗎啡藥物市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 止瀉藥
    • 疼痛管理
    • 感冒止咳藥
    • 其他

第 9 章：嗎啡藥物市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局
    • 其他

第 10 章：嗎啡藥物市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 門診手術中心
    • 醫院和診所
    • 其他

第 11 章：嗎啡藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 嗎啡藥物北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按劑型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 嗎啡藥物歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按劑型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 嗎啡藥物亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按劑型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 嗎啡藥物拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按劑型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 嗎啡藥物中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按劑型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 嗎啡藥品產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Mallinckrodt Pharmaceuticals
    • AbbVie Inc.
    • Delpharm (Sandoz Canada Inc.)
    • Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
    • Daiichi Sankyo Company Limited
    • Verve Health Care Ltd
    • Hikma Pharmaceuticals USA Inc.
    • Sun Pharmaceutical Industries Ltd
    • Viatris Inc.
    • Alcaliber SA
    • Sanofi

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2233

REPORT HIGHLIGHT

Morphine Drugs Market size was valued at USD 22,870 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

When other medications are ineffective or intolerable for the patient, morphine is used to treat moderate to severe pain. An opioid drug called morphine is used to treat pain, either chronic or acute, and it typically works quite well. As an opiate (narcotic) analgesic, morphine is a member of this class of drugs. Through its binding to the mu-opioid receptors in the central nervous system (CNS) and peripheral nervous system (PNS), morphine alters the way the brain and nervous system react to pain.

Morphine Drugs Market- Market Dynamics

Rising geriatric population along with chronic illness drives the market growth

Over the projection period, the demand for different opioid medications like morphine is predicted to rise due to the growing elderly population and the rising prevalence of chronic illnesses. Chronic pain and osteoarthritis diseases are more common in the elderly population. In May 2021, the MDPI published a report indicating that chronic pain was a significant problem impacting over 50% of the elderly population. In addition, it is predicted that the rising prevalence of arthritis would increase demand for painkillers. The Arthritis Society Canada estimates that 50% of those over 65 suffer from arthritis. Thus, during the course of the forecast period, the growing number of people experiencing chronic pain worldwide is anticipated to propel the morphine market.

Morphine Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on dosage form segmentation, injection was predicted to show maximum market share in the year 2023

Based on application segmentation, pain management was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Morphine Drugs Market- Segmentation Analysis:

The Global Morphine Drugs Market is segmented based on Dosage Form, Application, Distribution Channel, End Use, and Region.

The market is divided into three categories based on dosage form: Oral, Injection and Others. Injection sector dominates the market. The purpose of these injections is to relieve moderate to severe pain. It can also be used with an anesthetic before to or during surgery. Among the companies in this market are Duramorph, Infumorph, and Astramorph PF.

The market is divided into two categories based on application: Diarrhea Suppressant, Pain Management, Cold & Cough Suppressant and Others. The pain management sector dominates the market and is likely to maintain its dominance during the forecast period due to the widespread usage of morphine as a pain reliever. It can be used to treat or reduce pain from a variety of illnesses, including significant trauma from accidents, labor pain, cancer pain, and surgical pain.

Morphine Drugs Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The market is expected to expand more robustly in the presence of established players. Over the projection period, the growing prevalence of musculoskeletal disorders and the strong demand in the pharmaceutical industry are also anticipated to support the regional expansion. As to the April 2020 factsheet released by the Department of Justice and Drug Enforcement Administration, morphine derived from opium is utilized directly in medicinal goods within the United States. Consequently, the region's market demand may be driven over the projection period by the usage of morphine in the pharmaceutical industry.

Morphine Drugs Market- Competitive Landscape:

The market players operating in the Morphine Drugs market are Pfizer Inc., Mallinckrodt Pharmaceuticals, AbbVie Inc., Delpharm (Sandoz Canada Inc.), Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited), Daiichi Sankyo Company Limited, Verve Health Care Ltd, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries Ltd, Viatris Inc., Alcaliber S.A and Sanofi among others. These players adopted various strategies to hold a maximum market share such as product launches, acquisitions, expansion and others.

Recent Developments:

In July 2022, one lot of thirty milligram and one lot of sixty milligram extended-release morphine sulfate tablets (10 bottles each) were voluntarily recalled by Bryant Ranch Prepack Inc. from consumer distribution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MORPHINE DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Mallinckrodt Pharmaceuticals

AbbVie Inc.

Delpharm (Sandoz Canada Inc.)

Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)

Daiichi Sankyo Company Limited

Verve Health Care Ltd

Hikma Pharmaceuticals USA Inc.

Sun Pharmaceutical Industries Ltd

Viatris Inc.

Alcaliber S.A

Sanofi

GLOBAL MORPHINE DRUGS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injection
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diarrhea Suppressant
  • Pain Management
  • Cold & Cough Suppressant
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Ambulatory Surgical Centers
  • Hospitals & Clinics
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Morphine Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Morphine Drugs Market Snippet by Dosage Form
    • 2.1.2. Morphine Drugs Market Snippet by Application
    • 2.1.3. Morphine Drugs Market Snippet by Distribution Channel
    • 2.1.4. Morphine Drugs Market Snippet by End Use
    • 2.1.5. Morphine Drugs Market Snippet by Country
    • 2.1.6. Morphine Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Morphine Drugs Key Market Trends

  • 3.1. Morphine Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Morphine Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Morphine Drugs Market Opportunities
  • 3.4. Morphine Drugs Market Future Trends

4. Morphine Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Morphine Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Morphine Drugs Market Landscape

  • 6.1. Morphine Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Morphine Drugs Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Injection
    • 7.1.4. Others

8. Morphine Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diarrhea Suppressant
    • 8.1.3. Pain Management
    • 8.1.4. Cold & Cough Suppressant
    • 8.1.5. Others

9. Morphine Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Others

10. Morphine Drugs Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 10.1.2. Ambulatory Surgical Centers
    • 10.1.3. Hospitals & Clinics
    • 10.1.4. Others

11. Morphine Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Morphine Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Morphine Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Morphine Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Morphine Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Morphine Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Morphine Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Mallinckrodt Pharmaceuticals
    • 12.2.3. AbbVie Inc.
    • 12.2.4. Delpharm (Sandoz Canada Inc.)
    • 12.2.5. Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
    • 12.2.6. Daiichi Sankyo Company Limited
    • 12.2.7. Verve Health Care Ltd
    • 12.2.8. Hikma Pharmaceuticals USA Inc.
    • 12.2.9. Sun Pharmaceutical Industries Ltd
    • 12.2.10. Viatris Inc.
    • 12.2.11. Alcaliber S.A
    • 12.2.12. Sanofi

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Morphine Drugs Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Morphine Drugs Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Morphine Drugs Market, by Application 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Morphine Drugs Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: End Use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Morphine Drugs Market, by End Use 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Morphine Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by End Use, 2019-2032 (USD Million)